Identifying a next-generation antimalarial trioxolane in a landscape of artemisinin partial resistance
{{output}}
For over two decades, artemisinin-based combination therapy (ACT) has been the standard of care for the treatment of uncomplicated falciparum malaria. However, artemisinin partial resistance (ART-R) is now prevalent in Southeast Asia and has emerged in eastern... ...
